PLASMA PROATRIAL NATRIURETIC FACTOR IS PREDICTIVE OF CLINICAL STATUS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

Citation
K. Dickstein et al., PLASMA PROATRIAL NATRIURETIC FACTOR IS PREDICTIVE OF CLINICAL STATUS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, The American journal of cardiology, 76(10), 1995, pp. 679-683
Citations number
29
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
00029149
Volume
76
Issue
10
Year of publication
1995
Pages
679 - 683
Database
ISI
SICI code
0002-9149(1995)76:10<679:PPNFIP>2.0.ZU;2-L
Abstract
Atrial stretch results in myocyte release of the prohormone atrial nat riuretic factor (1-126). The N-terminal (1-98) fragment, proatrial nat riuretic factor (proANF) is released on an equimolar basis with the C- terminal (99-126) active hormone and may be assayed simply due to in v itro stability. This study was undertaken to evaluate the relation bet ween proANF and routinely available measures of clinical status. ProAN F was sampled from 202 patients (median age 68 years [range 15 to 85], 77% men) recruited from an active outpatient heart failure clinic. Pa tients were subgrouped according to New York Heart Association functio nal class, radionuclide ejection fraction (EF), echocardiographic left ventricular (LV) end-diastolic diameter, and Doppler-determined systo lic pulmonary arterial pressure. The median proANF (pmol/L) values for patients in New York Heart Association classes I, II, III, and IV wer e 725, 1,527, 1,750, and 5,172, respectively. The proANF value for the group with EF >40% was 1,534 versus 1,993 for EF less than or equal t o 40% (p <0.05). The value for the group with LV diameter <60 mm was 8 38 versus 1,751 for LV diameter greater than or equal to 60 mm (p <0.0 1). the value for the group with systolic pulmonary artery pressure <4 5 mm Hg was 1,241 versus 2,660 for systolic pulmonary artery pressure greater than or equal to 45 mm Hg (p <0.01). ProANF correlated better than the other variables with New York Heart Association functional cl ass and was more closely associated with noninvasive measurements than New York Heart Association functional class. Odds ratio estimates dem onstrated a substantially increased risk of LV dysfunction and dilatat ion, pulmonary hypertension, and New York Heart Association functional class III or IV with increasing proANF valves. These data clearly ind icate that the concentration of proANF is related to the degree of cli nical heart failure. Analysis is simple and should be of practical val ue as a supplement in the routine assessment of cardiac status in this heterogeneous population.